Viewing StudyNCT04047953



Ignite Creation Date: 2024-05-06 @ 1:31 PM
Last Modification Date: 2024-10-26 @ 1:15 PM
Study NCT ID: NCT04047953
Status: RECRUITING
Last Update Posted: 2023-04-05
First Post: 2019-08-06

Brief Title: Paclitaxel Albumin-bound Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
Sponsor: Peking University Cancer Hospital Institute
Organization: Peking University Cancer Hospital Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-09-10
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-11
Completion Date Type: ESTIMATED
First Submit Date: 2019-08-06
First Submit QC Date: August 6 2019
Study First Post Date: 2019-08-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-04
Last Update Post Date: 2023-04-05
Last Update Post Date Type: ACTUAL